title: Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.
abstract: Recurrent respiratory papillomatosis is a viral-induced disease, associated with exophytic epithelial lesions affecting the upper airways. Problem of treatment is the high recurrence of papilloma growth after surgical removal; therefore, adjuvant therapy schemes have been established. We used cidofovir, 7.5 mg/ml, in adjuvant therapy in the past years. Out of 31 adult patients treated with the drug, 26 (83.9 %) are at the moment in complete response. 19 (73 % of pts with CR) of those 26 patients were cured with a number of injections between 1 and 4 (mean 2.5). We did not see any clinical manifestation of renal toxicity or neutropenia (superinfection) necessitating a blood test. Six patients presented dysplasia during the treatment with the drug, while six patients had dysplasia prior to cidofovir injection. Due to recurrent nature of the disease and the high number of mechanical and laser surgeries required we treated one tracheal stenosis, two scarred larynx, and two glottic synechiaes. There is still an ongoing discussion within the European Laryngological Society about the effectiveness and possible side effects of this drug. Results show promising long-term effects of adjuvant use of cidofovir, without any relevant side effects.
authors.affiliation: Otorhinolaryngology Section, Department of Sensorial Organs, "Sapienza" University of Rome, Rome, Italy, michelegrasso87@libero.it.
authors.forename: M
authors.initials: M
authors.lastname: Grasso
authors.forename: M
authors.initials: M
authors.lastname: Remacle
authors.forename: V
authors.initials: V
authors.lastname: Bachy
authors.forename: S
authors.initials: S
authors.lastname: Van Der Vorst
authors.forename: G
authors.initials: G
authors.lastname: Lawson
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000998:Antiviral Agents / Q000008:administration & dosage; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000008:administration & dosage*; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000188:drug therapy* / Q000821:virology; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000821:virology; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir
references.citation: Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1051-4
references.pmid: 20517629
references.citation: Laryngoscope. 2004 Nov;114(11 Pt 2 Suppl 104):1-23
references.pmid: 15514560
references.citation: Otolaryngol Clin North Am. 2012 Jun;45(3):671-94, viii-ix
references.pmid: 22588043
references.citation: Ugeskr Laeger. 2011 Feb 14;173(7):506-7
references.pmid: 21320416
references.citation: J Pathol. 1991 Nov;165(3):243-6
references.pmid: 1662265
references.citation: Eur Arch Otorhinolaryngol. 2007 Jan;264(1):63-70
references.pmid: 17058091
references.citation: Otolaryngol Pol. 2011 Nov-Dec;65(6):436-42
references.pmid: 22208941
references.citation: Otolaryngol Head Neck Surg. 2012 Sep;147(3):522-4
references.pmid: 22597574
references.citation: Otolaryngol Head Neck Surg. 2011 Feb;144(2):252-6
references.pmid: 21493426
references.citation: Laryngoscope. 2010 Apr;120(4):698-702
references.pmid: 20205173
references.citation: Eur J Cancer Prev. 2008 Aug;17(4):340-4
references.pmid: 18562959
references.citation: APMIS. 2010 Jun;118(6-7):450-4
references.pmid: 20553527
references.citation: Laryngoscope. 2010 Feb;120(2):253-8
references.pmid: 19998420
references.citation: Acta Dermatovenerol Alp Pannonica Adriat. 2011 Sep;20(3):175-80
references.pmid: 22131118
references.citation: Eur Arch Otorhinolaryngol. 2011 Sep;268(9):1305-11
references.pmid: 21519834
references.citation: Ann Otol Rhinol Laryngol. 2008 Jul;117(7):477-83
references.pmid: 18700421
references.citation: Laryngoscope. 2010 Aug;120(8):1602-8
references.pmid: 20641080
references.citation: Clin Pharmacokinet. 1999 Feb;36(2):127-43
references.pmid: 10092959
references.citation: Mod Pathol. 2000 Aug;13(8):914-8
references.pmid: 10955460
references.citation: Eur J Pediatr. 2011 Mar;170(3):309-21
references.pmid: 20686784
references.citation: Ann Otol Rhinol Laryngol. 2006 Sep;115(9):667-72
references.pmid: 17044537
references.citation: Laryngoscope. 2012 Jul;122(7):1595-9
references.pmid: 22565595
references.citation: Eur Arch Otorhinolaryngol. 2012 Feb;269(2):361-2
references.pmid: 22020697
references.citation: B-ENT. 2012;8(3):197-202
references.pmid: 23113383
references.citation: Eur Arch Otorhinolaryngol. 2013 Feb;270(2):641-6
references.pmid: 23070260
references.citation: Eur Arch Otorhinolaryngol. 2007 May;264(5):499-504
references.pmid: 17377801
references.citation: Eur Arch Otorhinolaryngol. 2003 Apr;260(4):219-22
references.pmid: 12709807
references.citation: J Voice. 2013 Jan;27(1):124-8
references.pmid: 23102824
references.citation: Pediatr Dev Pathol. 2001 Jan-Feb;4(1):68-72
references.pmid: 11200493
references.citation: Eur Arch Otorhinolaryngol. 2013 May;270(5):1679-87
references.pmid: 23377227
references.citation: Eur Arch Otorhinolaryngol. 2012 Jul;269(7):1833-7
references.pmid: 22101746
references.citation: Acta Otolaryngol. 2007 Nov;127(11):1196-201
references.pmid: 17851940
references.citation: Jpn J Clin Oncol. 2013 Jan;43(1):78-82
references.pmid: 23110763
references.citation: Eur Arch Otorhinolaryngol. 2006 May;263(5):440-3
references.pmid: 16328406
references.citation: Laryngoscope. 2013 Mar;123(3):705-12
references.pmid: 23070868
references.citation: Head Neck. 2009 Aug;31(8):1095-101
references.pmid: 19072996
references.citation: Cochrane Database Syst Rev. 2012 Dec 12;12:CD005053
references.pmid: 23235619
references.citation: Eur Arch Otorhinolaryngol. 2008 Aug;265(8):871-9
references.pmid: 18458927